Joseph Ohanlon, DO
Surgery · Cambridge, OHNPI 1427287325
Payments from drug & device makers
Across 38 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$207
- Takeda Pharmaceuticals U.S.A., Inc.$123
- Phathom Pharmaceuticals, Inc.$58
- Pacira Pharmaceuticals Incorporated$37
- Baxter Healthcare$34
- Exact Sciences$33
- plus $201 from 11 others
What the payments were for
- Food & beverage$692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $123 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Baxter Healthcare | 2 | $34 |
| Exact Sciences | 1 | $33 |
| Northgate Technologies, Inc. | 1 | $22 |
| Monaghan Medical Corporation | 1 | $22 |
| Sanofi | 1 | $21 |
| Mindray DS USA, Inc. | 1 | $21 |
| Covidien LP | 1 | $18 |
| Olympus America Inc. | 1 | $18 |
| Endogastric Solutions, Inc | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Davol Inc. | 1 | $11 |
How this compares
$692 in reported general payments places this provider in the 35th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 65 | $730 |
| Sucralfate | 45 | $687 |
| Pantoprazole Sodium | 15 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $153 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $133 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cambridge
- Jonathan ThompsonWest Chester$2.2M
- Raymond OndersCleveland$1.2M
- Clayton PetroCleveland$1.1M
- Ali AminianCleveland$1.1M
- Michael RosenCleveland$983K
- Michael MearaColumbus$868K
- Neilendu KunduCleveland$808K
- Chase WehrleCleveland$741K
- Ihya GorgunCleveland$704K
- Craig JarrettCleveland$622K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.